Chronic News and Research

RSS

Genmab reaches milestone for Arzerra under terms of collaboration with GSK

Genmab A/S announced today it has reached a milestone for Arzerra(ofatumumab) under the terms of its collaboration with GlaxoSmithKline.

23 Apr 2010

Patients more likely to change diet with written plan combined with counseling calls

Combining telephone counseling calls with a daily written diet plan increases a person's success in improving fruit and vegetables consumption, according to research published in Preventive Medicine.

23 Apr 2010

Geron scientists highlight importance of telomerase inhibitor, GRN163L at AACR 2010

Geron Corporation today announced five presentations by Geron scientists and collaborators on the company's telomerase inhibitor, imetelstat sodium, including the drug's activity against cancer stem cells, at the 101st American Association for Cancer Research annual meeting held in Washington D.C.

23 Apr 2010

FirstPath Advantage program developed to close gap on health care continuum

A unique approach to health management was recently announced by FirstSolutions and BeniComp, Inc. The program, FirstPath Advantage, has been developed to close the gap on the health care continuum and dramatically impact employer claims costs.

23 Apr 2010

Long-term monitoring of young leukaemia survivors necessary to identify declining lung health: Researchers

Children who have survived leukaemia may need to have regular monitoring to ensure their lungs remain healthy if they had a bone marrow transplantation during their treatment, US scientists have said.

23 Apr 2010

BTA Charitable Foundation to gift $1 million to Courage Centre at GRH

In a landmark giving announcement for the Glenrose Rehabilitation Hospital Foundation (GRHF), the Building Trades of Alberta (BTA) Charitable Foundation announced today that they will give $1 million to the Courage Centre at the Glenrose Rehabilitation Hospital (GRH). The Charitable Foundation is the beneficiary of the philanthropic efforts of the Building Trades of Alberta's 16 affiliated unions and 22 locals with a combined membership of over 60,000 unionized skilled trades people.

23 Apr 2010

Treating OSA in truck drivers lowers healthcare costs and disability rates: Study

For commercial motor vehicle drivers with obstructive sleep apnea, effective treatment lowers healthcare costs and disability rates, reports a study in the May Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.

23 Apr 2010

Hospital for Special Care launches ALS Clinical Trials Unit at Neuromuscular Center

Hospital for Special Care announced today the launch of the region's first Amyotrophic Lateral Sclerosis (ALS) Clinical Trials Unit at its Neuromuscular Center. The new unit will be headed by Jinsy A. Andrews, M.D., a physician researcher recruited from Columbia University. Dr. Andrews, Director of Research & Clinical Trials Unit, Hospital for Special Care, specializes in neuromuscular research and will facilitate the hospital's first clinical trial for ALS upon her arrival.

23 Apr 2010

Mayo Clinic study finds changes in tissue damage throughout the course of MS

A new Mayo Clinic study has found that the type of tissue damage changes throughout the course of multiple sclerosis. In early relapsing disease stages, the plaques, or areas where the nervous system is inflamed or demyelinated, are predominantly active with distinct heterogeneous patterns of myelin damage.

23 Apr 2010

Affymax institutes quiet period in connection with Hematide Phase 3 result analysis

Affymax, Inc. today announced that it has instituted a quiet period to curtail discussions with the investor community and the media in connection with the analysis of Phase 3 results for the investigational drug, Hematide, in four clinical trials (PEARL 1, PEARL 2, EMERALD 1 and EMERALD 2) which evaluated Hematide for the treatment of anemia in chronic renal failure patients.

23 Apr 2010

Amira Pharmaceuticals granted UK patent covering novel small molecule inhibitors of DP2 receptor

Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual Property Office has granted it patent number GB2460597 titled "N,N-Disubstituted aminoalkylBiPhenyl Antagonists OF Prostaglandin d2 RECEPTORS."

23 Apr 2010

Accredo Health Group selected as sole specialty pharmacy provider of Epoprostenol for Injection

Actelion Pharmaceuticals US, Inc., today announced that it has selected Accredo Health Group, Inc., a wholly-owned subsidiary of Medco Health Solutions, Inc., to serve as the sole specialty pharmacy provider of Epoprostenol for Injection, the only epoprostenol formulated to provide up to 24-hour stability at room temperature without the use of ice packs.

22 Apr 2010

Alexion Pharmaceuticals reports total revenues of $117.6M from net product sales of Soliris

Alexion Pharmaceuticals, Inc. today announced financial results for the quarter ended March 31, 2010.

22 Apr 2010

Los Angeles slum housing health crisis

Over three hundred community members, stakeholders, and public health workers joined Los Angeles County Supervisor Mark Ridley-Thomas for a People's Hearing on Slum Housing and the unveiling of a position paper documenting the health crisis related to slum housing in Los Angeles.

22 Apr 2010

Human lymphocytes produce hepcidin that regulate iron levels in the body: Study

For some years now a small group of scientists have been pioneering a revolutionary idea - that the vertebrate immune system could have a role in the regulation of iron in the body. And now, a work soon to be published in the journal Immunology, shows that human lymphocytes (white blood cells) actually produce hepcidin, the most important protein in the regulation of iron levels in the body.

22 Apr 2010

KSERA research project focuses on COPD patients

To enable elderly people to live at home as long as possible, a group of European researchers, coordinated from Eindhoven University of Technology, will link robots and 'smart homes'. The robot, a 'sensible family friend', will ensure that home is a nice place to stay. And that patients do the right things.

22 Apr 2010

Need for better understanding potential dangers of prescription painkillers

In response to a study published in the April issue of the American Journal of Preventive Medicine called "Hospitalizations for Poisoning by Prescription Opioids, Sedatives, and Tranquilizers," the Waismann Method of Opiate Detoxification is urging Americans to take measures to better understand and recognize the potential dangers and addictive nature of prescription painkillers.

22 Apr 2010

Chronic News and Research

Genmab reaches milestone for Arzerra under terms of collaboration with GSK

Patients more likely to change diet with written plan combined with counseling calls

Geron scientists highlight importance of telomerase inhibitor, GRN163L at AACR 2010

FirstPath Advantage program developed to close gap on health care continuum

Long-term monitoring of young leukaemia survivors necessary to identify declining lung health: Researchers

BTA Charitable Foundation to gift $1 million to Courage Centre at GRH

Treating OSA in truck drivers lowers healthcare costs and disability rates: Study

Hospital for Special Care launches ALS Clinical Trials Unit at Neuromuscular Center

Mayo Clinic study finds changes in tissue damage throughout the course of MS

Affymax institutes quiet period in connection with Hematide Phase 3 result analysis

Amira Pharmaceuticals granted UK patent covering novel small molecule inhibitors of DP2 receptor

Accredo Health Group selected as sole specialty pharmacy provider of Epoprostenol for Injection

Alexion Pharmaceuticals reports total revenues of $117.6M from net product sales of Soliris

Los Angeles slum housing health crisis

Human lymphocytes produce hepcidin that regulate iron levels in the body: Study

KSERA research project focuses on COPD patients

Need for better understanding potential dangers of prescription painkillers

New studies on cancer prevention presented at 101st AACR Annual Meeting 2010

Colorado Governor moves forward with implementing reforms; Nevada community health centers feel financial pinch

Medical use of marijuana on its way to reality in Washington D.C.

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News